The current valuation score of Arcellx Inc is 7.10, ranking 167 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -28.30, which is -81.67% below the recent high of -5.19 and -433.77% above the recent low of -151.06.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.